Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial.

Giustino, Gennaro; Tijssen, Jan; Windecker, Stephan; Dangas, George (2020). Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial. Cardiovascular research, 116(3), e39-e41. Oxford University Press 10.1093/cvr/cvaa026

[img] Text
Rivaroxaban after transcatheter aortic valve replacement.pdf - Published Version
Restricted to registered users only
Available under License BORIS Standard License.

Download (213kB) | Request a copy

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0008-6363

Publisher:

Oxford University Press

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

04 Nov 2020 16:03

Last Modified:

15 Nov 2020 02:44

Publisher DOI:

10.1093/cvr/cvaa026

PubMed ID:

32077477

Uncontrolled Keywords:

Aortic stenosis Rivaroxaban TAVR

BORIS DOI:

10.7892/boris.147266

URI:

https://boris.unibe.ch/id/eprint/147266

Actions (login required)

Edit item Edit item
Provide Feedback